Christopher W Mangieri
19PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (19)
Sort by Publication Date:
|Mar 04, 2025
ASO Visual Abstract: Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) of Extraperitoneal Abdominal Disease, Is it Appropriate?Christopher W Mangieri, Konstantinos I Votanopoulos, Perry Shen
|Feb 04, 2025
Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) of Extraperitoneal Abdominal Disease, is it Appropriate?Christopher W Mangieri, Konstantinos I Votanopoulos, Perry Shen
|Feb 03, 2025
ASO Author Reflections: Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) of Extraperitoneal Abdominal Disease, a Likely Common Practice but Infrequently Reported.Christopher W Mangieri, Edward A Levine
|Jun 17, 2023
Risk factors and outcomes for cholangitis after hepatic resection.Christopher W Mangieri, Matthew A Strode, Omeed Moaven
|Jan 05, 2023
ASO Author Reflections: Neoadjuvant Oxaliplatin Therapy for Peritoneal Carcinomatosis, Any Impact on Subsequent Hyperthermic Intraperitoneal Chemotherapy Perfusion?Christopher W Mangieri, Edward A Levine
|Dec 09, 2022
Exposure to Neoadjuvant Oxaliplatin-Containing Chemotherapy, Does it Effect Intraperitoneal Hyperthermic Chemotherapy Perfusion?Christopher W Mangieri, Cristian D Valenzuela, Ian B Solsky
Pageof 4
